Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism [4]

British Journal of Haematology

Volumn 138, Issue 3, 2007, Pages 400-403

  Lobo, Jose Luís ^a   Jiménez, David ^b   Orue, Ma Teresa ^c   Grau, Enric ^d   Naufall, Dolores ^e   Madridano, Olga ^f   Monreal, Manuel ^g  

^a HOSPITAL TXAGORRITXU   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Instituto de Investigación Sanitaria de Navarra   (Spain)

^d HOSPITAL LLUÍS ALCANYÍS   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anticoagulants; Risk factors; Thrombosis (venous)

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; COUMARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; TREATMENT RESPONSE; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

AGED; COUMARINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; REGISTRIES; VENOUS THROMBOSIS; VITAMIN K;

EID: 34447136188     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06679.x     Document Type: Letter

References (10)

1. Büller, H.R., Agnelli, G., Hull, R.D., Hyers, T.M., Prins, M.H. Raskob, G.E. (2004) Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126, 401S 428S.
2. Cherian, J. Gertner, E. (2005) Recurrent pulmonary embolism despite inferior vena cava filter placement in patients with antiphospholipid syndrome. Journal of Clinical Rheumatology, 11, 56 58.
3. Douketis, J.D., Foster, G.A., Crowther, M.A., Prins, M.H. Ginsberg, J.S. (2000) Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Archives of Internal Medicine, 160, 3431 3436.
4. Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A.G., McLoughlin, D., Dodd, P., Thomas, M., Raskob, G. Ockelford, P. (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. The New England Journal of Medicine, 307, 1676 1681.
5. Lee, A.Y.Y., Levine, M.N., Baker, R.I., Bowden, C., Kakkar, A.K., Prins, M., Rickles, F.R., Julian, J.A., Haley, S., Kovacs, M.J. Gent, M. for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the CLOT Investigators (2003) Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine, 349, 146 153.
6. Luk, C., Wells, P.S., Anderson, D. Kovacs, M.J. (2001) Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. American Journal of Medicine, 111, 270 273.
7. Monreal, M., Suárez, C., González Fajardo, J.A., Barba, R., Uresandi, F., Valle, R. Rondón, P. the RIETE Investigators (2003/2004) Management of patients with acute venous thromboembolism: findings from the RIETE Registry. Pathophysiology of Haemostasis and Thrombosis, 33, 330 334.
8. Prandoni, P., Lensing, A.W., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M.H., Noventa, F. Girolami, A. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 3484 3488.
9. Trujillo-Santos, J., Herrera, S., Page, M.A., Soto, M.J., Raventós, A., Sánchez, R. Monreal, M. for the RIETE Investigators (2006) Predicting adverse outcome in outpatients with acute deep vein thrombosis. findings from the RIETE Registry. Journal of Vascular Surgery, 44, 789 793.
10. Veeger, N.J., Piersma, N.J., Tijssen, J.G., Hillege, H.L. van der Meer, J. (2005) Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. British Journal of Haematology, 128, 513 519.